5-HT4 receptor antagonists for the treatment of heart failure
US8829028B2 · kind B2 · utility
3Cited by
26References
25Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Feb 17, 2009 |
| Grant date | Sep 9, 2014 |
| Priority date | — |
| Expiry date | Aug 11, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2300/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention provides the use of a 5-HT4 receptor antagonist in the manufacture of a medicament for treating or preventing heart failure. Particular heart disorders to be treated are selected from the group comprising chronic heart failure, congestive heart failure, chronic congestive heart failure and heart failure resulting from ischaemic heart disease. Methods of treating heart failure using 5-HT4 receptor antagonists and pharmaceutical compositions containing 5-HT4 receptor antagonists are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.